Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)

Por Diessner, J, Bruttel, V, Stein, R G, Horn, E, Häusler, S F M, Dietl, J, Hönig, A, Wischhusen, J
Publicado em 2014

Chemotherapy for 70-Year-Old Women with Breast Cancer in Germany: A Survey by the German Breast Group

Por Barinoff, J., Traut, A., Bauerschlag, D., Bischoff, J., Herr, D., Lübbe, K., Lück, H.-J., Maass, N., Mundhenke, C., Schmidt, M., Schwedler, K., Thill, M., Steffen, J., Loibl, S., von Minckwitz, G.
Publicado em 2013

Coordination of Care for Early-stage Breast Cancer Patients

Por Bickell, Nina A, Young, Gary J
Publicado em 2001

mTOR function and therapeutic targeting in breast cancer

Por Hare, Stephen H, Harvey, Amanda J
Publicado no Am J Cancer Res (2017)

Breast cancer survivors’ perspectives on whether clinical staff should ask breast cancer patients about childhood abuse

Por Clark, L, Holcombe, C, Fisher, J, Salmon, P
Publicado no Ann R Coll Surg Engl (2014)

Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation

Por Zee, J van der, Holt, B van der, Rietveld, P J M, Helle, P A, Wijnmaalen, A J, Putten, W L J van, Rhoon, G C van
Publicado em 1999

Mammographic screening detects low-risk tumor biology breast cancers

Por Drukker, C. A., Schmidt, M. K., Rutgers, E. J. T., Cardoso, F., Kerlikowske, K., Esserman, L. J., van Leeuwen, F. E., Pijnappel, R. M., Slaets, L., Bogaerts, J., van’t Veer, L. J.
Publicado em 2014

Prognostic significance of cathepsin-D in patients with breast cancer.

Por Winstanley, J. H., Leinster, S. J., Cooke, T. G., Westley, B. R., Platt-Higgins, A. M., Rudland, P. S.
Publicado em 1993

Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer

Por Anderson, T J, Dixon, J M, Stuart, M, Sahmoud, T, Miller, W R
Publicado em 2002

Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.

Por Järvinen, T. A., Holli, K., Kuukasjärvi, T., Isola, J. J.
Publicado em 1998

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group.

Por Bontenbal, M., Andersson, M., Wildiers, J., Cocconi, G., Jassem, J., Paridaens, R., Rotmensz, N., Sylvester, R., Mouridsen, H. T., Klijn, J. G., van Oosterom, A. T.
Publicado em 1998

Family history and risk of breast cancer: an analysis accounting for family structure

Por Brewer, Hannah R., Jones, Michael E., Schoemaker, Minouk J., Ashworth, Alan, Swerdlow, Anthony J.
Publicado no Breast Cancer Res Treat (2017)

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage

Por Howell, S J, Searle, C, Goode, V, Gardener, T, Linton, K, Cowan, R A, Harris, M A, Hopwood, P, Swindell, R, Norman, A, Kennedy, J, Howell, A, Wardley, A M, Radford, J A
Publicado em 2009

Hsp90, an unlikely ally in the war on cancer

Por Barrott, Jared J., Haystead, Timothy A. J.
Publicado em 2013

Review of quantitative multiscale imaging of breast cancer

Por Pinkert, Michael A., Salkowski, Lonie R., Keely, Patricia J., Hall, Timothy J., Block, Walter F., Eliceiri, Kevin W.
Publicado no J Med Imaging (Bellingham) (2018)

Radiation Pneumonitis After Conventional Radiotherapy For Breast Cancer: A Prospective Study

Por Jeba, Jenifer, Isiah, Rajesh, Subhashini, J, Backianathan, Selvamani, Thangakunam, Balamugesh, Christopher, Devasagayam J
Publicado no J Clin Diagn Res (2015)

Radiation Pneumonitis After Conventional Radiotherapy For Breast Cancer: A Prospective Study

Por Jenifer Jeba, Rajesh Isiah, J Subhashini, Selvamani Backianathan, Balamugesh Thangakunam, Devasagayam J Christopher
Publicado em 2015-07-01

Is clinical breast examination important for breast cancer detection?

Por Provencher, L., Hogue, J.C., Desbiens, C., Poirier, B., Poirier, E., Boudreau, D., Joyal, M., Diorio, C., Duchesne, N., Chiquette, J.
Publicado no Curr Oncol (2016)

Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.

Por Marks, J R, Humphrey, P A, Wu, K, Berry, D, Bandarenko, N, Kerns, B J, Iglehart, J D
Publicado em 1994

Serum sialyl transferase levels in patients with metastatic breast cancer treated by chemotherapy.

Por Stewart, J. F., Rubens, R. D., Hoare, S., Bulbrook, R. D., Kessel, D.
Publicado em 1982